Anakinra drug retention rate and predictive factors of drug survival in systemic juvenile idiopathic arthritis and adult onset Still’s disease.

J Sota; Donato Rigante; A Insalaco; P Sfriso; S de Vita; R Cimaz; G Lopalco; G Emmi; F La Torre; C Fabiani; An Olivieri; M Cattalini; D Cammelli; R Gallizzi; M Alessio; Raffaele Manna; O Viapiana; M Frassi; A Maier; C Salvarani; R Talarico; R Priori; Mc Maggio; M Pardeo; C Gaggiano; S Grosso; F De Benedetti; A Vitale; L Cantarini

Anakinra drug retention rate and predictive factors of drug survival in systemic juvenile idiopathic arthritis and adult onset Still’s disease.

J Sota, Donato Rigante, A Insalaco, P Sfriso, S de Vita, R Cimaz, G Lopalco, G Emmi, F La Torre, C Fabiani, An Olivieri, M Cattalini, D Cammelli, R Gallizzi, M Alessio, Raffaele Manna, O Viapiana, M Frassi, A Maier, C SalvaraniR Talarico, R Priori, Mc Maggio, M Pardeo, C Gaggiano, S Grosso, F De Benedetti, A Vitale, L Cantarini

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

We have evaluated anakinra drug retention rate and predictive factors of drug survival in a cohort of patients with systemic juvenile idiopathic arthritis (sJIA) and adult onset Still’s disease (AOSD). Our findings show an overall excellent drug retention rate of anakinra on the long run for both sJIA and AOSD that may be further optimized by closely monitoring patient’s safety issues and employing this interleukin-1 inhibitor as a first-line biologic drug as early as possible. Moreover, the use of anakinra allowed a significant other drug-sparing effect while showing a good safety profile.

Lingua originale	English
pagine (da-a)	1-2
Numero di pagine	2
Rivista	PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL
Volume	10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
Stato di pubblicazione	Pubblicato - 2019

Keywords

Anakinra

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Sota, J., Rigante, D., Insalaco, A., Sfriso, P., de Vita, S., Cimaz, R., Lopalco, G., Emmi, G., La Torre, F., Fabiani, C., Olivieri, A., Cattalini, M., Cammelli, D., Gallizzi, R., Alessio, M., Manna, R., Viapiana, O., Frassi, M., Maier, A., ... Cantarini, L. (2019). Anakinra drug retention rate and predictive factors of drug survival in systemic juvenile idiopathic arthritis and adult onset Still’s disease. PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL, 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID), 1-2.

@article{7149e95ce9b346d0b72b422601679683,

title = "Anakinra drug retention rate and predictive factors of drug survival in systemic juvenile idiopathic arthritis and adult onset Still{\textquoteright}s disease.",

abstract = "We have evaluated anakinra drug retention rate and predictive factors of drug survival in a cohort of patients with systemic juvenile idiopathic arthritis (sJIA) and adult onset Still{\textquoteright}s disease (AOSD). Our findings show an overall excellent drug retention rate of anakinra on the long run for both sJIA and AOSD that may be further optimized by closely monitoring patient{\textquoteright}s safety issues and employing this interleukin-1 inhibitor as a first-line biologic drug as early as possible. Moreover, the use of anakinra allowed a significant other drug-sparing effect while showing a good safety profile.",

keywords = "Anakinra, Anakinra",

author = "J Sota and Donato Rigante and A Insalaco and P Sfriso and {de Vita}, S and R Cimaz and G Lopalco and G Emmi and {La Torre}, F and C Fabiani and An Olivieri and M Cattalini and D Cammelli and R Gallizzi and M Alessio and Raffaele Manna and O Viapiana and M Frassi and A Maier and C Salvarani and R Talarico and R Priori and Mc Maggio and M Pardeo and C Gaggiano and S Grosso and {De Benedetti}, F and A Vitale and L Cantarini",

year = "2019",

language = "English",

volume = "10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)",

pages = "1--2",

journal = "PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL",

issn = "1546-0096",

publisher = "[Chicago. Ill. : University of Chicago, 2003]-",

}

Sota, J, Rigante, D, Insalaco, A, Sfriso, P, de Vita, S, Cimaz, R, Lopalco, G, Emmi, G, La Torre, F, Fabiani, C, Olivieri, A, Cattalini, M, Cammelli, D, Gallizzi, R, Alessio, M, Manna, R, Viapiana, O, Frassi, M, Maier, A, Salvarani, C, Talarico, R, Priori, R, Maggio, M, Pardeo, M, Gaggiano, C, Grosso, S, De Benedetti, F, Vitale, A & Cantarini, L 2019, 'Anakinra drug retention rate and predictive factors of drug survival in systemic juvenile idiopathic arthritis and adult onset Still’s disease.', PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL, vol. 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID), pagg. 1-2.

Anakinra drug retention rate and predictive factors of drug survival in systemic juvenile idiopathic arthritis and adult onset Still’s disease. / Sota, J; Rigante, Donato; Insalaco, A et al.
In: PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL, Vol. 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID), 2019, pag. 1-2.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - Anakinra drug retention rate and predictive factors of drug survival in systemic juvenile idiopathic arthritis and adult onset Still’s disease.

AU - Sota, J

AU - Rigante, Donato

AU - Insalaco, A

AU - Sfriso, P

AU - de Vita, S

AU - Cimaz, R

AU - Lopalco, G

AU - Emmi, G

AU - La Torre, F

AU - Fabiani, C

AU - Olivieri, An

AU - Cattalini, M

AU - Cammelli, D

AU - Gallizzi, R

AU - Alessio, M

AU - Manna, Raffaele

AU - Viapiana, O

AU - Frassi, M

AU - Maier, A

AU - Salvarani, C

AU - Talarico, R

AU - Priori, R

AU - Maggio, Mc

AU - Pardeo, M

AU - Gaggiano, C

AU - Grosso, S

AU - De Benedetti, F

AU - Vitale, A

AU - Cantarini, L

PY - 2019

Y1 - 2019

N2 - We have evaluated anakinra drug retention rate and predictive factors of drug survival in a cohort of patients with systemic juvenile idiopathic arthritis (sJIA) and adult onset Still’s disease (AOSD). Our findings show an overall excellent drug retention rate of anakinra on the long run for both sJIA and AOSD that may be further optimized by closely monitoring patient’s safety issues and employing this interleukin-1 inhibitor as a first-line biologic drug as early as possible. Moreover, the use of anakinra allowed a significant other drug-sparing effect while showing a good safety profile.

AB - We have evaluated anakinra drug retention rate and predictive factors of drug survival in a cohort of patients with systemic juvenile idiopathic arthritis (sJIA) and adult onset Still’s disease (AOSD). Our findings show an overall excellent drug retention rate of anakinra on the long run for both sJIA and AOSD that may be further optimized by closely monitoring patient’s safety issues and employing this interleukin-1 inhibitor as a first-line biologic drug as early as possible. Moreover, the use of anakinra allowed a significant other drug-sparing effect while showing a good safety profile.

KW - Anakinra

UR - http://hdl.handle.net/10807/136253

M3 - Article

SN - 1546-0096

VL - 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)

SP - 1

EP - 2

JO - PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL

JF - PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL

ER -

Anakinra drug retention rate and predictive factors of drug survival in systemic juvenile idiopathic arthritis and adult onset Still’s disease.

Abstract

Keywords

Altri file e collegamenti

Fingerprint

Cita questo